审查目前获得许可的粘膜COVID-19疫苗
Alina Tscherne1, Florian Krammer2
1Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria.
Vaccine
|June 7, 2025
概括
下一代粘膜COVID-19疫苗旨在通过诱导呼吸道免疫来增强保护. 虽然研究有希望,但需要更多的人类数据来确认它们在阻断感染和传播方面的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 传染性疾病 传染性疾病
背景情况:
- 可注射的COVID-19疫苗降低了死亡率,但缺乏强大的粘膜免疫力.
- 粘膜免疫对于预防SARS-CoV-2感染和传播至关重要.
- 下一代疫苗的目标是诱导粘膜和全身免疫反应.
研究的目的:
- 审查关于粘膜COVID-19疫苗的当前知识.
- 总结关于它们有效性的临床前和临床研究结果.
- 突出了对人类粘膜体疫苗反应的进一步研究的需要.
主要方法:
- 对粘膜COVID-19疫苗的临床前和临床试验数据的审查.
- 对免疫反应的分析,包括分泌IgA和记忆细胞.
- 对SARS-CoV-2感染,复制和传播的保护的评估.
主要成果:
- 粘膜疫苗在临床前和临床试验中显示出保护作用.
- 疗效与分泌IgA和呼吸道记忆细胞有关.
- 对于已批准的粘膜疫苗,关于感染/传播阻断的人类数据有限.
结论:
- 粘膜疫苗代表了下一代COVID-19预防的有希望的战略.
- 进一步的研究对于验证它们在人类中的有效性至关重要.
- 了解粘膜免疫是控制病毒性呼吸道感染的关键.
关键词:
已批准的COVID-19疫苗已经获得批准.这就是BioBlock.临床试验中的临床试验.这就是Convidecia Air的目的地.获得许可的COVID-19疫苗粘膜的粘膜是可以使用的.这就是Pneucolin.拉齐科夫帕斯帕斯是什么意思这就是SARS-CoV-2病毒.斯普特尼克五号 斯普特尼克五号在 iNCOVACCC 中,您可以使用更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.9K
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.7K
相关概念视频
Cancer Vaccines
522
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
522
Vaccinations
45.4K
Overview
45.4K
